In the hypothyroid kidney, exogenous adenosine (ADO) produces vasodilation
and restores renal function to near-normal values. This study evaluates whe
ther this response is mediated by nitric oxide synthesis stimulated by aden
osine. GFR and urinary excretion of NO2-/NO3- (UNO2-/NO3-) were measured in
normal (NL) and hypothyroid (HTX) rats under basal conditions and during i
nfusion of: intra-aortic ADO, intravenously, 1,3-dipropyl-8p-sulfophenylxan
thine (DPSPX), 8-cyclopentyl-1,3-dipropyl xanthine (DPCPX), N-omega-nitro-L
-arginine methylester (L-NAME) + ADO, L-NAME + PSPX, L-NAME + DPCPX, and in
trarenal (IR) ADO or DPCPX + IR ADO. Intra-aortic ADO induced a fall in GFR
and increased UNO2-/NO3- slightly in NL rats; in HTX rats, both GFR and UN
O2-/NO3- increased significantly. DPSPX and DPCPX in creased UNO2-/NO3- exc
retion in NL animals with minor changes in GFR; the blockers increased both
GFR and UNO2-/NO3- in HTX rats. L-NAME completely blocked the increase in
NO2-/NO3- induced by ADO, DPSPX, and DPCPX. The intrarenal infusion of ADO
at 1, 10, and 35 nmol/kg per mill progressively decreased GFR with a slight
increase in UNO2-/ NO3 in NL rats; in the HTX, GFR increased with the high
est dose and UNO2-/NO3- progressively increased. DPCPX prevented the fall i
n GFR induced by intrarenal ADO in NL rats, with no further changes in UNO2
-/NO3- in HTX rats, intrarenal ADO under A1 blockade further increased GFR
and UNO2/NO3. Arterial and venous ADO concentrations were lower in the HTX
rats. In the HTX kidney, NO production was stimulated by ADO, most likely t
hrough activation of A2 or A3 receptors, whereas A1 receptors had an inhibi
tory effect. Thus, ADO receptors are involved in the regulation of kidney f
unction in pathophysiologic conditions.